by Misty Severi
The Trump administration said Monday two more major pharmacuetical companies will be launching popular medication on the discounted pharmaceutical site TrumpRx.
The White House launched the website in February, which is a government-run, direct-to-consumer portal that is considered instrumental in helping the Trump administration lower prescription drug costs in the U.S.
At the State of the Union later in February, Trump said, “I’m also ending the wildly inflated cost of prescription drugs like has never happened before. Other presidents tried to do it, but they never could. They tried.”
“I took prescription drugs, a very big part of health care, from the highest price in the entire world to the lowest. That’s a big achievement. The result is price differences of 300, 400, 500, 600 percent and more, all available right now at a new website called TrumpRx.gov,” the president said.
The companies Abbvie and Genentech are expected to become the 10th and 11th drug-making companies to release their products at a discounted rate on the portal, joining other giants like AstraZeneca, Eli Lilly, Novo Nordisk and Pfizer.
Abbvie will sell its popular medication Humira, which is used to treat rheumatoid arthritis, Crohn’s disease and ulcerative colitis, on the site at an 86% discount, according to CBS News. Genentech will sell its flu-prevention drug Xofluza.
The Humira pen is now expected to cost uninsured Americans $950, down from as high as $6,900, and a prescription of Xofluza will cost $50 instead of $168, the outlet reported.
The new additions will bring the total up to 61 drugs that the website now offers at a discounted price. TrumpRx offered discounted prices for 40 of the most popular and expensive medications in the country, including Ozempic and Wegovy, which help treat diabetes, heart disease and obesity, at its launch.
– – –
Misty Severi is a reporter for Just the News. Zachery Schmidt is the digital editor of The Star News Network and contributed to this story.
